Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates in the Gulf Cooperation Council states: Dominance of OXA-23-type producers

Journal of Clinical Microbiology

Volumn 53, Issue 3, 2015, Pages 896-903

  Zowawi, Hosam M ^a,b,c   Sartor, Anna L ^a   Sidjabat, Hanna E ^a   Balkhy, Hanan H ^b,c   Walsh, Timothy R ^a,d   Johani, Sameera M Al ^b,e   Aljindan, Reem Y ^f   Alfaresi, Mubarak ^g,h   Ibrahim, Emad ⁱ   Al Jardani, Amina ^j   Salman, Jameela Al ^c,k   Dashti, Ali A ^l   Johani, Khalid ^m,n   Paterson, David L ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^f IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

^g ZAYED MILITARY HOSPITAL   (United Arab Emirates)

^h Khalifa Hospital   (United Arab Emirates)

ⁱ HAMAD MEDICAL CORPORATION   (Qatar)

^j ROYAL HOSPITAL   (Oman)

^k Infectious Diseases Unit   (Bahrain)

^l KUWAIT UNIVERSITY   (Kuwait)

^m The General Directorate of Armed Forces Health Services   (Saudi Arabia)

ⁿ MACQUARIE UNIVERSITY   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; CARBAPENEM; CARBAPENEMASE; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; OXA 23; OXA 24; OXA 40; OXA 51; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TETRACYCLINE; TIMENTIN; UNCLASSIFIED DRUG; BETA LACTAMASE; CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; AGRICULTURE; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL GENE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BAHRAIN; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII; CHILD; CLONAL VARIATION; CLONE; COMMUNITY; FEMALE; HEALTH CARE; HOSPITAL; HUMAN; INFANT; INFECTION CONTROL; KUWAIT; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; OMAN; PATIENT TRANSPORT; POLYMERASE CHAIN REACTION SYSTEM; PRIORITY JOURNAL; QATAR; SAUDI ARABIA; UNITED ARAB EMIRATES; ACINETOBACTER INFECTIONS; CLASSIFICATION; CLUSTER ANALYSIS; DRUG EFFECTS; ENZYMOLOGY; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MICROBIOLOGY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD;

ACINETOBACTER BAUMANNII;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CHILD, PRESCHOOL; CLUSTER ANALYSIS; FEMALE; GENOTYPE; HOSPITALS; HUMANS; INFANT; MALE; MIDDLE EAST; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; POLYMERASE CHAIN REACTION;

EID: 84923333003     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02784-14     Document Type: Article

References (49)

1. El-Saed A, Balkhy HH, Al-Dorzi HM, Khan R, Rishu AH, Arabi YM. 2013. Acinetobacter is the most common pathogen associated with lateonset and recurrent ventilator-associated pneumonia in an adult intensive care unit in Saudi Arabia. Int J Infect Dis 17:e696-e701. http://dx.doi.org/10.1016/j.ijid.2013.02.004.
2. Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21:538-582. http://dx.doi.org/10.1128/CMR.00058-07.
3. Zowawi HM, Balkhy HH, Walsh TR, Paterson DL. 2013. Beta-lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula. Clin Microbiol Rev 26:361-380. http://dx.doi.org/10.1128/CMR.00096-12.
4. Al-Agamy MH, Khalaf NG, Tawfick MM, Shibl AM, El Kholy A. 2014. Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt. Int J Infect Dis 22:49-54. http://dx.doi.org/10.1016/j.ijid.2013.12.004.
5. Bonnin RA, Poirel L, Naas T, Pirs M, Seme K, Schrenzel J, Nordmann P. 2012. Dissemination of New Delhi metallo-beta-lactamase-1-producing Acinetobacter baumannii in Europe. Clin Microbiol Infect 18:E362-E365. http://dx.doi.org/10.1111/j.1469-0691.2012.03928.x.
6. Espinal P, Poirel L, Carmeli Y, Kaase M, Pal T, Nordmann P, Vila J. 2013. Spread of NDM-2-producing Acinetobacter baumannii in the Middle East. J Antimicrob Chemother 68:1928-1930. http://dx.doi.org/10.1093/jac/dkt109.
7. Yang J, Chen Y, Jia X, Luo Y, Song Q, Zhao W, Wang Y, Liu H, Zheng D, Xia Y, Yu R, Han X, Jiang G, Zhou Y, Zhou W, Hu X, Liang L, Han L. 2012. Dissemination and characterization of NDM-1-producing Acinetobacter pittii in an intensive care unit in China. Clin Microbiol Infect 18:E506-E513. http://dx.doi.org/10.1111/1469-0691.12035.
8. Kapiszewski A. 2006. Arab versus Asian migrant workers in the GCC countries, UN/POP/EGM/2006/02. In United Nations Expert Group Meeting on International Migration and Development in the Arab Region, Beirut, Lebanon.
9. Memish ZA. 2010. The Hajj: communicable and non-communicable health hazards and current guidance for pilgrims. Euro Surveill 15:19671. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19671.
10. Zowawi HM, Sartor AL, Balkhy HH, Walsh TR, Al Johani SM, Al Jindan RY, Alfaresi M, Ibrahim E, Al-Jardani A, Al-Abri S, Al Salman J, Dashti AA, Kutbi AH, Schlebusch S, Sidjabat HE, Paterson DL. 2014. Molecular characterization of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the countries of the Gulf Cooperation Council: dominance of OXA-48 and NDM producers. Antimicrob Agents Chemother 58:3085-3090. http://dx.doi.org/10.1128/AAC.02050-13.
11. European Committee on Antimicrobial Susceptibility Testing (EUCAST). 2014. Breakpoint tables for interpretation of MICs and zone diameters, version 4. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/Breakpoint-tables/Breakpoint-table-v-4.0.pdf
12. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; 24th informational supplement. CLSI M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
13. Higgins PG, Lehmann M, Wisplinghoff H, Seifert H. 2010. gyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3. J Clin Microbiol 48:4592-4594. http://dx.doi.org/10.1128/JCM.01765-10.
14. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SG, Livermore DM. 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27:351-353. http://dx.doi.org/10.1016/j.ijantimicag.2006.01.004.
15. Afzal-Shah M, Woodford N, Livermore DM. 2001. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 45:583-588. http://dx.doi.org/10.1128/AAC.45.2.583-588.2001.
16. Lim S. 2011. Development of multiplex PCR: β-lactamase genes and virulence determinants in E. Coli. University of Queensland Centre for Clinical Research, Brisbane St Lucia, Australia.
17. Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo JD, Nordmann P. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallobetalactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother 44:891-897. http://dx.doi.org/10.1128/AAC.44.4.891-897.2000.
18. Ellington MJ, Kistler J, Livermore DM, Woodford N. 2007. Multiplex PCR for rapid detection of genes encoding acquired metallo-betalactamases. J Antimicrob Chemother 59:321-322. http://dx.doi.org/10.1093/jac/dkl481.
19. Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, Pitt TL. 2006. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 258:72-77. http://dx.doi.org/10.1111/j.1574-6968.2006.00195.x.
20. CMY-7 and associated plasmid-mediated resistance genes in multidrug-resistant Escherichia coli isolated from dogs at a veterinary teaching hospital in Australia. J Antimicrob Chemother 57:840-848. http://dx.doi.org/10.1093/jac/dkl057.
21. Hojabri Z, Pajand O, Bonura C, Aleo A, Giammanco A, Mammina C. 2014. Molecular epidemiology of Acinetobacter baumannii in Iran: endemic and epidemic spread of multiresistant isolates. J Antimicrob Chemother 69:2383-2387. http://dx.doi.org/10.1093/jac/dku045.
22. Pasanen T, Koskela S, Mero S, Tarkka E, Tissari P, Vaara M, Kirveskari J. 2014. Rapid molecular characterization of Acinetobacter baumannii clones with rep-PCR and evaluation of carbapenemase genes by new multiplex PCR in Hospital District of Helsinki and Uusimaa. PLoS One 9:e85854. http://dx.doi.org/10.1371/journal.pone.0085854.
23. Bartual SG, Seifert H, Hippler C, Luzon MA, Wisplinghoff H, Rodriguez-Valera F. 2005. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol 43:4382-4390. http://dx.doi.org/10.1128/JCM.43.9.4382-4390.2005.
24. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ. 2002. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137:791-797. http://dx.doi.org/10.7326/0003-4819-137-10-200211190-00007.
25. Aly M, Tayeb HT, Al Johani SM, Alyamani EJ, Aldughaishem F, Alabdulkarim I, Balkhy HH. 2014. Genetic diversity of OXA-51-like genes among multidrug-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia. Eur J Clin Microbiol Infect Dis 33:1223-1228. http://dx.doi.org/10.1007/s10096-014-2068-0.
26. Bonnin RA, Rotimi VO, Al Hubail M, Gasiorowski E, Al Sweih N, Nordmann P, Poirel L. 2013. Wide dissemination of GES-type carbapenemases in Acinetobacter baumannii isolates in Kuwait. Antimicrob Agents Chemother 57:183-188. http://dx.doi.org/10.1128/AAC.01384-12.
27. Fouad M, Attia AS, Tawakkol WM, Hashem AM. 2013. Emergence of carbapenem-resistant Acinetobacter baumannii harboring the OXA-23 carbapenemase in intensive care units of Egyptian hospitals. Int J Infect Dis 17:e1252-1254. http://dx.doi.org/10.1016/j.ijid.2013.07.012.
28. Merino M, Poza M, Roca I, Barba MJ, Sousa MD, Vila J, Bou G. 2014. Nosocomial outbreak of a multiresistant Acinetobacter baumannii expressing OXA-23 carbapenemase in Spain. Microb Drug Resist 20:259-263. http://dx.doi.org/10.1089/mdr.2013.0127.
29. Dettori M, Piana A, Deriu MG, Lo Curto P, Cossu A, Musumeci R, Cocuzza C, Astone V, Contu MA, Sotgiu G. 2014. Outbreak of multidrugresistant Acinetobacter baumannii in an intensive care unit. New Microbiol 37:185-191. http://www.newmicrobiologica.org/PUB/allegati-pdf/2014/2/185.pdf.
30. Perez F, Endimiani A, Ray AJ, Decker BK, Wallace CJ, Hujer KM, Ecker DJ, Adams MD, Toltzis P, Dul MJ, Windau A, Bajaksouzian S, Jacobs MR, Salata RA, Bonomo RA. 2010. Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination. J Antimicrob Chemother 65:1807-1818. http://dx.doi.org/10.1093/jac/dkq191.
31. Ahmed-Bentley J, Chandran AU, Joffe AM, French D, Peirano G, Pitout JD. 2013. Gram-negative bacteria that produce carbapenemases causing death attributed to recent foreign hospitalization. Antimicrob Agents Chemother 57:3085-3091. http://dx.doi.org/10.1128/AAC.00297-13.
32. Sabat AJ, Budimir A, Nashev D, Sa-Leao R, Van Dijl J, Laurent F, Grundmann H, Friedrich AW, ESCMID Study Group of Epidemiological Markers (ESGEM). 2013. Overview of molecular typing methods for outbreak detection and epidemiological surveillance. Euro Surveill 18:20380. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20380.
33. Adams-Haduch JM, Onuoha EO, Bogdanovich T, Tian GB, Marschall J, Urban CM, Spellberg BJ, Rhee D, Halstead DC, Pasculle AW, Doi Y. 2011. Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States. J Clin Microbiol 49:3849-3854. http://dx.doi.org/10.1128/JCM.00619-11.
34. Deng M, Zhu MH, Li JJ, Bi S, Sheng ZK, Hu FS, Zhang JJ, Chen W, Xue XW, Sheng JF, Li LJ. 2014. Molecular epidemiology and mechanisms of tigecycline resistance in clinical isolates of Acinetobacter baumannii from a Chinese university hospital. Antimicrob Agents Chemother 58:297-303. http://dx.doi.org/10.1128/AAC.01727-13.
35. Li Y, Pan C, Zhao Z, Zhao Z, Chen H, Lu W. 2013. Effects of a combination of amlodipine and imipenem on 42 clinical isolates of Acinetobacter baumannii obtained from a teaching hospital in Guangzhou, China. BMC Infect Dis 13:548. http://dx.doi.org/10.1186/1471-2334-13-548.
36. Tada T, Miyoshi-Akiyama T, Shimada K, Shimojima M, Kirikae T. 2014. Dissemination of 16S rRNA methylase ArmA-producing Acinetobacter baumannii and emergence of OXA-72 carbapenemase coproducers in Japan. Antimicrob Agents Chemother 58:2916-2920. http://dx.doi.org/10.1128/AAC.01212-13.
37. OXA-51-like genes in patients with diabetes mellitus. J Chemother 21:290-295. http://dx.doi.org/10.1179/joc.2009.21.3.290.
38. Abdalhamid B, Hassan H, Itbaileh A, Shorman M. 2014. Characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates in a tertiary care hospital in Saudi Arabia. New Microbiol 37:65-73. http://www.newmicrobiologica.org/PUB/allegati-pdf/2014/1/65.pdf.
39. NDM-1 in clinical Acinetobacter baumannii isolates from India. Antimicrob Agents Chemother 58:4211-4213. http://dx.doi.org/10.1128/AAC.02500-14.
40. Sartor AL, Raza MW, Abbasi SA, Day KM, Perry JD, Paterson DL, Sidjabat HE. 2014. Molecular epidemiology of NDM-1-producing Enterobacteriaceae and Acinetobacter baumannii isolates from Pakistan. Antimicrob Agents Chemother 58:5589-5593. http://dx.doi.org/10.1128/AAC.02425-14.
41. Zhang R, Hu YY, Yang XF, Gu DX, Zhou HW, Hu QF, Zhao K, Yu SF, Chen GX. 2014. Emergence of NDM-producing non-baumannii Acinetobacter spp. isolated from China. Eur J Clin Microbiol Infect Dis 33:853-860. http://dx.doi.org/10.1007/s10096-013-2024-4.
42. - producing Acinetobacter baumannii isolated in Lebanon from civilians wounded during the Syrian war. Int J Infect Dis 21:21-23. http://dx.doi.org/10.1016/j.ijid.2014.01.004.
43. Decousser JW, Jansen C, Nordmann P, Emirian A, Bonnin RA, Anais L, Merle JC, Poirel L. 2013. Outbreak of NDM-1-producing Acinetobacter baumannii in France, January to May 2013. Euro Surveill 18: pii=20547. http://www.eurosurveillance.org/ViewArticle.aspx?Article Id=20547.
44. VIM mediated carbapenem resistance in Pseudomonas and Acinetobacter species in India. J Infect Dev Ctries 6:757-762. http://dx.doi.org/10.3855/jidc.2268.
45. Robledo IE, Aquino EE, Sante MI, Santana JL, Otero DM, Leon CF, Vazquez GJ. 2010. Detection of KPC in Acinetobacter spp. in Puerto Rico. Antimicrob Agents Chemother 54:1354-1357. http://dx.doi.org/10.1128/AAC.00899-09.
46. Robledo IE, Aquino EE, Vazquez GJ. 2011. Detection of the KPC gene in Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii during a PCR-based nosocomial surveillance study in Puerto Rico. Antimicrob Agents Chemother 55:2968-2970. http://dx.doi.org/10.1128/AAC.01633-10.
47. Balkhy HH, El-Saed A, Maghraby R, Al-Dorzi HM, Khan R, Rishu AH, Arabi YM. 2014. Drug-resistant ventilator associated pneumonia in a tertiary care hospital in Saudi Arabia. Ann Thorac Med 9:104-111. http://dx.doi.org/10.4103/1817-1737.128858.
48. Balkhy HH, Bawazeer MS, Kattan RF, Tamim HM, Al Johani SM, Aldughashem FA, Al Alem HA, Adlan A, Herwaldt LA. 2012. Epidemiology of Acinetobacter spp.-associated healthcare infections and colonization among children at a tertiary-care hospital in Saudi Arabia: a 6-year retrospective cohort study. Eur J Clin Microbiol Infect Dis 31:2645-2651. http://dx.doi.org/10.1007/s10096-012-1608-8.
49. Chopra T, Marchaim D, Johnson PC, Awali RA, Doshi H, Chalana I, Davis N, Zhao JJ, Pogue JM, Parmar S, Kaye KS. 2014. Risk factors and outcomes for patients with bloodstream infection due to Acinetobacter baumannii-calcoaceticus complex. Antimicrob Agents Chemother 58:4630-4635. http://dx.doi.org/10.1128/AAC.02441-14.